Terms: = Lung cancer AND KDSR, Q06136, 2531, ENSG00000119537, FVT1 AND Treatment
6 results:
1. Outcomes of Patients with Non-Small Cell lung cancer and Brain Metastases Treated with the Upfront Single Agent Pembrolizumab: A Retrospective and Multicentric Study of the ESCKEYP GFPC Cohort.
Nannini S; Guisier F; Curcio H; Ricordel C; Demontrond P; Abdallahoui S; Baloglu S; Greillier L; Chouaid C; Schott R
Curr Oncol; 2024 Mar; 31(3):1656-1666. PubMed ID: 38534959
[TBL] [Abstract] [Full Text] [Related]
2. Clinical Outcomes of Stereotactic Ablative Radiotherapy for All Stages of Non-Small Cell lung cancer; Definitive versus Consolidative.
Kim H; Kim SM; Yang DS; Lee KH; Kim YB
Medicina (Kaunas); 2022 Sep; 58(9):. PubMed ID: 36143981
[No Abstract] [Full Text] [Related]
3. [Experience and Progress Processing Policy of Simultaneous Multiple Primary
lung cancer].
Han L; Gao S; Tan F; Zhao Z; Song P
Zhongguo Fei Ai Za Zhi; 2018 Mar; 21(3):180-184. PubMed ID: 29587936
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathological characteristics and prognosis of patients with adenosquamous lung carcinoma.
Guo Y; Jia L; Shao GG; Sun HW; Wang XX; Wang GJ; Ma KW
J Huazhong Univ Sci Technolog Med Sci; 2015 Jun; 35(3):350-355. PubMed ID: 26072072
[TBL] [Abstract] [Full Text] [Related]
5. Clinical outcomes of atypical carcinoid tumors of the lung and thymus: 7-year experience of a rare malignancy at single institute.
Han B; Sun JM; Ahn JS; Park K; Ahn MJ
Med Oncol; 2013 Mar; 30(1):479. PubMed ID: 23377986
[TBL] [Abstract] [Full Text] [Related]
6. [A prospective randomized controlled clinical trial of irinotecan plus cisplatin versus gemcitabine plus cisplatin as a first-line treatment for advanced non-small cell lung cancer].
Zhao WY; Chen DY
Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):775-9. PubMed ID: 23291073
[TBL] [Abstract] [Full Text] [Related]
